Developing Interpretation Bias Modification as a "Cognitive Vaccine" for Depressed Mood: Imagining Positive Events Makes You Feel Better Than Thinking About Them Verbally
Developing Interpretation Bias Modification as a "Cognitive Vaccine" for Depressed Mood: Imagining Positive Events Makes You Feel Better Than Thinking About Them Verbally
复制标题
DOI：
10.1037/a0012590
复制
发表时间：
2009-02-01
影响因子：
4.6
通讯作者：
Shah, Dhruvi M.
中科院分区：
文献类型：
--
作者：
Holmes, Emily A.;Lang, Tamara J.;Shah, Dhruvi M.
两个解释偏差修正实验发现，心理意象与言语加工的积极材料有不同的情绪效果。在实验1中，参与者被要求想象积极解决的听觉描述或听相同的事件，同时思考他们的口头意义。积极情绪和偏见的增加在想象中比在言语条件下更大，复制E。A. Holmes，A.马修斯，T。达格利什和B。Macklett（2006）.情绪脆弱性测试表明，图像（相对于口头条件）保护对后来的负面情绪诱导。实验2创造了两个新的语言条件，旨在增加或减少语言比较。结果表明，与高度积极的材料进行不利的比较可能是部分负责实验1中的言语条件的劣性。研究结果表明，图像可以发挥关键作用，认知偏差的修改程序，因此，任务指令是至关重要的。想象一件积极的事情会让你感觉更好，而不是口头上思考同样的事情。作者提出，招募意象将有助于开发抑郁情绪的“认知疫苗”的治疗创新。
Two interpretation bias modification experiments found that mental imagery vs. verbal processing of positive material have differential emotional effects. In Experiment 1, participants were instructed to imagine positively resolved auditory descriptions or to listen to the same events while thinking about their verbal meaning. Increases in positive mood and bias were greater in the imagery than in the verbal condition, replicating E. A. Holmes, A. Mathews, T. Dalgleish, and B. Mackintosh (2006). An emotional vulnerability test showed that imagery (relative to the verbal condition) protected against a later negative mood induction. Experiment 2 created 2 new verbal conditions aimed to increase or reduce verbal comparisons. Results suggest making unfavorable comparisons with the highly positive material might be partially responsible for the inferiority of the verbal condition in Experiment 1. The findings demonstrate that imagery can play a key role in cognitive bias modification procedures and thus that task instructions are crucial. Imagining a positive event can make you feel better than thinking about the same event verbally. The authors propose that recruiting imagery will be useful in therapeutic innovations to develop a "cognitive vaccine" for depressed mood.